PubRank

Michel D Kazatchkine

Author PubWeight™ 79.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Medicine. The need for a global HIV vaccine enterprise. Science 2003 4.70
2 Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004 2.56
3 Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 2007 1.83
4 High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003 1.80
5 Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. Int J Drug Policy 2007 1.75
6 The prevalence of proteolytic antibodies against factor VIII in hemophilia A. N Engl J Med 2002 1.62
7 Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 2007 1.57
8 The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004 1.56
9 Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 2002 1.46
10 Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS 2003 1.45
11 High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004 1.39
12 Shortage of human intravenous immunoglobulin--reasons and possible solutions. Nat Clin Pract Neurol 2007 1.35
13 In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci U S A 2008 1.34
14 Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 2004 1.30
15 Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 2002 1.25
16 Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci U S A 2004 1.24
17 Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat Clin Pract Rheumatol 2007 1.23
18 Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002 1.14
19 Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci 2004 1.13
20 Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J Immunol 2002 1.06
21 Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 2005 1.04
22 Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies. Transfus Apher Sci 2007 1.01
23 Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women. J Infect Dis 2003 1.00
24 High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci U S A 2005 0.99
25 Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 2005 0.98
26 Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer 2008 0.97
27 Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun Rev 2008 0.96
28 Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner. J Immunol 2007 0.95
29 DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells. Proc Natl Acad Sci U S A 2009 0.94
30 Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling. Int J Drug Policy 2014 0.94
31 Contraceptive use in HIV-positive women. J Acquir Immune Defic Syndr 2004 0.93
32 High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women. J Acquir Immune Defic Syndr 2005 0.92
33 A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes. Proc Natl Acad Sci U S A 2007 0.92
34 Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. Cancer Lett 2006 0.90
35 Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1. J Immunol 2005 0.89
36 Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus. Arthritis Rheum 2003 0.89
37 Modulation of human dendritic cell maturation and function by natural IgG antibodies. Autoimmun Rev 2008 0.88
38 Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system. FASEB J 2002 0.88
39 Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity. Anticancer Res 2009 0.87
40 Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins. Mol Med 2002 0.87
41 Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int Immunopharmacol 2005 0.87
42 Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1. AIDS 2007 0.87
43 Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy. Am J Clin Pathol 2003 0.87
44 Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells. J Virol 2002 0.86
45 Enhanced transcytosis of R5-tropic human immunodeficiency virus across tight monolayer of polarized human endometrial cells under pro-inflammatory conditions. Cytokine 2002 0.83
46 Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene. J Acquir Immune Defic Syndr 2002 0.83
47 Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. J Immunol 2006 0.82
48 Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. Int Immunol 2004 0.82
49 Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung 2006 0.82
50 Red blood cell transfusions are associated with alterations in self-reactive antibody repertoires of plasma IgM and IgG, independent of the presence of a specific immune response toward RBC antigens. Clin Immunol 2002 0.82
51 Autoreactive antibody repertoire is perturbed in atherosclerotic patients. Lab Invest 2003 0.81
52 Dendritic cells and autoimmunity. Autoimmun Rev 2004 0.80
53 Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin. Am J Med 2005 0.80
54 Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa. Eur J Gastroenterol Hepatol 2004 0.80
55 Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins. J Clin Immunol 2014 0.80
56 Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Immunology 2007 0.80
57 Intravenous immunoglobulin for infectious diseases: tailor-made or universal? J Infect Dis 2003 0.80
58 Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants? Nat Rev Immunol 2008 0.79
59 "Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies. PLoS Pathog 2011 0.79
60 Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin. Chemotherapy 2003 0.79
61 Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide. Open Virol J 2011 0.79
62 Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett 2005 0.79
63 Pathophysiology of catalytic antibodies. Immunol Lett 2005 0.79
64 Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci 2007 0.79
65 Intravenous immunoglobulin in neurological disorders: a mechanistic perspective. J Neurol 2005 0.78
66 Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia A. Thromb Haemost 2003 0.78
67 Human papillomavirus-related cervical and anal disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Curr HIV/AIDS Rep 2005 0.78
68 Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors. J Med Virol 2002 0.77
69 Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity. PLoS One 2013 0.77
70 Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene. J Acquir Immune Defic Syndr 2007 0.76
71 Natural autoantibodies: immune homeostasis and therapeutic intervention. Expert Rev Clin Immunol 2005 0.76
72 Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G. Blood Coagul Fibrinolysis 2006 0.76
73 Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients. Mod Pathol 2006 0.76
74 Immunomodulation of autoimmunity by intravenous immunoglobulin through interaction with immune networks. Vox Sang 2002 0.76
75 Autoantibodies to factor VIII. Autoimmun Rev 2002 0.76
76 Immunointervention for patients with HIV and tuberculosis. Lancet Infect Dis 2009 0.75
77 Intravenous immunoglobulin and dendritic cells. Clin Rev Allergy Immunol 2005 0.75
78 [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders]. Transfus Clin Biol 2007 0.75
79 Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A. J Immunol Methods 2002 0.75
80 Comparative study of the anti-inflammatory effect of two intravenous immunoglobulin preparations manufactured by different processes. Immunol Lett 2006 0.75
81 [Catalytic antibodies or "abzymes"]. Med Sci (Paris) 2003 0.75
82 Catalytic antibodies to factor VIII in haemophilia A. Blood Coagul Fibrinolysis 2003 0.75
83 Autoantibodies to factor VIII with catalytic activity. Autoimmun Rev 2003 0.75
84 [Immunomodulatory effects of intravenous immunoglobulins]. Presse Med 2004 0.75